Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts

Retrieved on: 2025-02-15 07:16:33

Tags for this article:

Click the tags to see associated articles and topics

Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts. View article details on hiswai:

Summary

The article discusses Moderna's updates on various vaccine trials, including COVID-19 and norovirus. Stephen Hoge mentions no GBS cases with the COVID vaccine, while focusing on demonstrating flu efficacy for a combo vaccine approval.

Article found on: finance.yahoo.com

View Original Article